Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H5NO2 |
Molecular Weight | 75.0666 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCC(O)=O
InChI
InChIKey=DHMQDGOQFOQNFH-UHFFFAOYSA-N
InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
Molecular Formula | C2H5NO2 |
Molecular Weight | 75.0666 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:14:33 UTC 2023
by
admin
on
Fri Dec 15 15:14:33 UTC 2023
|
Record UNII |
TE7660XO1C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
25922-6
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 520.1060
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
2389-5
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
2390-3
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
JECFA EVALUATION |
GLYCINE
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
13750-5
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 172.320
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47635-8
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
56681-0
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
WHO-ATC |
B05CX03
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47636-6
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
15135-7
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
32244-6
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
16919-3
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
2392-9
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47639-0
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 170.50
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
22650-6
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
25431-8
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
20644-1
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47638-2
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
44365-5
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
13397-5
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
30066-5
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47634-1
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
26929-0
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
26807-8
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
27325-0
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
32245-3
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47637-4
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
25921-8
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 310.532
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 582.5049
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
47633-3
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
55862-7
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
22709-0
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
DSLD |
177 (Number of products:5)
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
15143-1
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
2391-1
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
2393-7
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
DSLD |
92 (Number of products:1270)
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
LOINC |
22718-1
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 331.15
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
WHO-VATC |
QB05CX03
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
||
|
CFR |
21 CFR 172.812
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
TE7660XO1C
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
SUB12000MIG
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
15428
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
GLYCINE
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
100000091968
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
630
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
D005998
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
C524
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
750
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
TE7660XO1C
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
495
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
25936
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
DTXSID9020667
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
CHEMBL773
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
1411
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
56-40-6
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
m5796
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | Merck Index | ||
|
29947
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
57305
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
DB00145
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
4919
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | RxNorm | ||
|
1319
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
1295800
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY | |||
|
200-272-2
Created by
admin on Fri Dec 15 15:14:33 UTC 2023 , Edited by admin on Fri Dec 15 15:14:33 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
Binding assay
IC50
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|